Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Prevenar and Meningitec in Healthy Infants
NCT00581035Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2006
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 4 trial of pneumococcal 7-valent conjugate vaccine, Meningococcal group C polysaccharide conjugate vaccine in pneumococcal infection, Meningococcal infection caused by serogroup C Neisseria meningitidis, sponsored by Pfizer. Started Jan 2006; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccineMeningococcal group C polysaccharide conjugate vaccine
03
Conditions
pneumococcal infectionMeningococcal infection caused by serogroup C Neisseria meningitidis
Beyond the preview
Go deeper on NCT00581035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581035.